Virax Biolabs Group Ltd (VRAX) Return on equity 2023–2025
Virax Biolabs Group Ltd (VRAX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-106.4%FY2025 · since FY2023: -59.8% → -106.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -106.4% | +19.1 pp |
| FY2024 | -125.5% | -65.7 pp |
| FY2023 | -59.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice